Dries Dobbelaere

Dr. Dries Dobbelaere


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2024 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
CMCamille Moreau
Camille Moreau
APAdrien Paquot
Adrien Paquot
GAGustavo Soto Ares
Gustavo Soto Ares
ADAnne-Frédérique Dessein
Anne-Frédérique Dessein
BDBenoit Deprez
Benoit Deprez
DDDries Dobbelaere
Dries Dobbelaere

Verified
Journal Article
Open access
PDF file
ETEva Thimm
Eva Thimm
ARAnselma Riederer
Anselma Riederer
JVJerry Vockley
Jerry Vockley
DDDries Dobbelaere
Dries Dobbelaere
MWMonique Williams
Monique Williams
Regina EnsenauerRegina Ensenauer
Regina Ensenauer
Isovaleric acidemia (IVA, OMIM 243500) is an inherited disorder of leucine metabolism caused by a deficiency of isovaleryl-CoA dehydrogenase (IVD), leading to an accumulation of isovaleric acid and its derivates 3-hydroxyisovaleric acid, isovaleryl (C5)-carnitine and isovalerylglycine in body fluids. The clinical presentation is highly variable, ranging from life-threatening metabolic crises with metabolic acidosis and hyperammonemia to a clinically asymptomatic only biochemical phenotype. Newborn screening for IVA has been established in many countries. Treatment consists of a protein-restricted diet combined with supplementation of carnitine and/or glycine and emergency treatment in catabolic episodes. Still, evidence-based recommendations for the diagnosis and management of IVA patients with various phenotypes are lacking. Therefore, a systematic search and review of the literature was conducted to make suggestions for the care of patients with IVA based on both the available scientific evidence and consensus-derived expert conclusions. Based on a comprehensive set of literature data published between 1966 and 2024, 15 statements were phrased on the presentation, diagnosis, management, and outcome of IVA involving clinical, biochemical, and nutrition expertise. These statements can serve as a basis for more standardized care for IVA.